Smart Therapeutics: Often Less is More

In the pursuit of healthspan and longevity, it’s easy to get swept away by bold promises. Facebook ads, Instagram reels, and flashy “biohack” podcasts often suggest there’s a magic pill for energy, weight loss, or living longer. But nothing in life is that simple. Even treatments with proven benefits don’t work for everyone, and “natural” doesn’t always mean safe.

When it comes to supplements and longevity medications, dosage matters, timing matters, and individual biology matters. What helps one person may harm another. Let’s unpack why a thoughtful, personalized, physician-guided approach is the safest—and most effective—way forward.

1. Not All Supplements Are Harmless

One of the biggest misconceptions is that because supplements are sold over the counter, they’re automatically safe. The truth: many supplements have been linked to serious liver and kidney damage.

• A systematic review of gym users found that supplement use was linked to elevated markers of liver and kidney stress, even in otherwise healthy adults [1].
• A large review of published cases found over 12,000 reports of herbal or dietary supplement–induced liver injury between 2004 and 2020 [2].
• More recent analyses highlight supplements like ashwagandha, turmeric, green tea extract, and Garcinia cambogia as repeat offenders in causing herbal-induced liver injury (HILI) [3].
• Experts note that supplement-related liver injuries, while not as common as prescription drug reactions, tend to be more severe and harder to treat [4].
• On the kidney side, contaminated or poorly regulated herbal products have been shown to cause direct nephrotoxicity (kidney damage) [5].

For more, see the NIH’s official LiverTox database, which tracks supplements and drugs linked to liver injury.

2. Why Supplement Quality Matters

Unlike prescription drugs, supplements are not tightly regulated. Some are contaminated, mislabeled, or spiked with unlisted ingredients.

That means two bottles labeled the same way may not even contain the same thing. For example, red yeast rice supplements sometimes contain dangerous by-products like citrinin, which is toxic to the liver, or are secretly laced with pharmaceutical statins [6].

Pro tip: When choosing supplements, look for brands that follow Good Manufacturing Practices (GMP) and use third-party testing. Reputable companies will often display certifications such as:

• NSF Certified for Sport® — ensures supplements are tested for contaminants, banned substances, and label accuracy.
• USP Verified Mark — confirms purity, potency, and quality through rigorous independent testing.

These certifications don’t guarantee that a supplement is right for you—but they dramatically lower the risks of contamination or mislabeling.

3. Dose and Timing—Where “Less Is More”

Even safe nutrients can cause harm if you take too much or combine them incorrectly.

• Vitamin A is a classic example. It’s essential in small amounts, but chronic high doses can cause liver scarring and cirrhosis [7].
• Turmeric/curcumin, generally considered safe as a spice, has been linked to liver failure in rare cases when used at high supplement doses [3].
• A study testing carefully balanced multi-nutrient supplementation found that correct dosing could prevent stress-related liver and kidney strain during exercise, while avoiding harmful overdosing [8].

Timing also matters. Some supplements can block the absorption of medications or alter blood test results. “Stacking” multiple supplements with overlapping nutrients (like iron, vitamin A, selenium) can also lead to toxicity.

4. Longevity Drugs: Metformin Isn’t a Free Pass

Among longevity enthusiasts, metformin—a diabetes drug—has gained fame as a possible anti-aging pill. But the science is nuanced.

• In people with type 2 diabetes, metformin users sometimes live longer than those on other diabetes medications—but this advantage disappears after about five years [9].
• A long-term study in postmenopausal women found that those who took metformin had a 30% greater chance of reaching age 90 compared to women using other medications [10].
• The highly anticipated TAME trial (Targeting Aging with Metformin) is underway to test whether metformin helps healthy older adults—but results are not yet available, the trial ends in 2028[11].
• Experts caution that the benefits may be limited to people with insulin resistance or metabolic issues, not the general population [12].

Bottom line: metformin is not a universal anti-aging drug. For healthy people, the risks (like GI upset, vitamin B12 deficiency, or lactic acidosis) may outweigh the unclear benefits.

5. Rapamycin: Hype vs. Human Evidence

Another hot topic is rapamycin, a drug that extends lifespan in mice and other animals. But does it work in humans?

• Studies show rapamycin consistently prolongs life in animals, sometimes to the same extent as calorie restriction [13].
• A review in The Lancet Healthy Longevity found only a handful of human trials, most of them small, short, and focused on immune or skin effects—not lifespan [14].
• Experts caution that, for now, the hype far exceeds the evidence [15].
• The PEARL trial, one of the largest placebo-controlled human studies of rapamycin in healthy older adults, is very promising [16].
• However, off-label use has already caused issues: high-profile biohackers who experimented with rapamycin stopped after side effects like mouth ulcers, high cholesterol, and fatigue [17].

So while rapamycin is promising, it remains experimental, and using it outside clinical trials should be carefully monitored by a physician.

6. Why Animal Data Doesn’t Equal Human Results

Medical school teaches: kids are not just little adults—they metabolize drugs differently, so doses can’t just be scaled down. The same applies to animal research.

• Mice live 2–3 years; humans live decades. A “lifespan extension” in mice doesn’t guarantee meaningful benefit in humans.
• Metabolic pathways often differ between species. A dose that extends life in rodents could be unsafe or ineffective in people.

That’s why human trials—not animal hype—are the gold standard.

7. The Problem With “Biohack Culture”

From peptides to mystery powders, the wellness industry is exploding with new “miracle” substances. But many of these are untested, unregulated, and sometimes unsafe.

• Some peptides are sourced from overseas labs with questionable purity.
• Long-term effects are unknown.
• Stacking untested compounds with supplements and medications risks dangerous interactions.

In short: your body is not a science experiment.

8. A Smarter, Safer Approach

Here’s how to navigate supplements and longevity medicine responsibly:

1. Start with Lab Work
   • Get baseline tests for liver, kidney, hormones, blood sugar, cholesterol. Repeat regularly.
2. Consult a Physician
   • Work with a doctor trained in metabolic or integrative medicine. They can personalize your regimen and watch for red flags.
3. Start Low, Go Slow
   • Add one supplement at a time. Monitor how you feel and track labs.
4. Choose Trusted Brands
   • Stick with companies that have NSF or USP certification.
5. Match Therapy to Your Biology
   • Metformin might help someone with insulin resistance—but not a 25-year-old athlete.
   • Rapamycin may eventually become standard therapy, but for now, it’s an experiment.
6. Watch for Side Effects
   • Fatigue, GI upset, mouth ulcers, or abnormal labs should not be ignored.

9. Final Takeaway

The world of supplements and smart therapeutics is full of promise—and pitfalls.

• Supplements are not automatically safe. Many can damage the liver or kidneys when taken in the wrong dose or form.
• More is not better. Correct dosing and timing are critical.
• Metformin and rapamycin are exciting, but not universally applicable to everyone.
• Your health plan should be guided by data—labs, medical history, and physician oversight—not by Facebook ads or the latest Instagram trend.

Longevity isn’t about finding a magic pill. It’s about making careful, personalized choices that protect your health today and tomorrow.

References

1. Schlickmann S, de Souza AM, da Silva YS, et al. Liver and kidney function markers among gym users: the role of dietary supplement usage. British Journal of Nutrition. 2022;128(12):2402–2410. doi:10.1017/S0007114522001364
2. Teschke R, Eickhoff A, Andrade RJ. Herbal hepatotoxicity: A critical review. Medicines. 2021;8(1):6. doi:10.3390/medicines8010006
3. Björnsson ES. Herbal and dietary supplement-induced liver injury: An update. World Journal of Hepatology. 2021;13(9):1019–1037. doi:10.4254/wjh.v13.i9.1019
4. Chalasani N, Bonkovsky HL, Fontana RJ, et al. Drug-, herbal-, and dietary supplement–induced liver injury: clinical and research perspectives. Clinics in Liver Disease. 2019;23(1):75–104. doi:10.1016/j.cld.2018.09.002
5. Perazella MA. Nephrotoxicity of herbal supplements: A hidden epidemic. Kidney News. 2023;15(8):22–24. doi:10.1681/ksn.2023080953
6. Li D, Chen L, Chen X, et al. Red yeast rice and monacolin K–related toxicity. Food and Chemical Toxicology. 2019;131:110585. doi:10.1016/j.fct.2019.110585
7. Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. American Journal of Clinical Nutrition. 2006;83(2):191–201. doi:10.1093/ajcn/83.2.191
8. Chen CY, Tseng YJ, Hsu CH, et al. Multiple-nutrient supplementation mitigates exercise-induced liver and kidney function stress during heat stress. Frontiers in Nutrition. 2021;8:740741. doi:10.3389/fnut.2021.740741
9. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, Obesity and Metabolism. 2014;16(11):1165–1173. doi:10.1111/dom.12354
10. Gong J, Nichols HB, Garcia C, et al. Metformin use and survival to 90 years in postmenopausal women: results from the Women’s Health Initiative. Journal of Gerontology: Series A, Biological Sciences and Medical Sciences. 2025;80(5):876–884. doi:10.1093/gerona/glae043
11. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. The Metformin in Longevity Study (MILES): Targeting Aging with Metformin (TAME). Geroscience. 2016;38(4):373–380. doi:10.1007/s11357-016-9882-2
12. Attia P. Metformin and longevity: examining the evidence. PeterAttiaMD.com. Published online 2022. Available at: https://peterattiamd.com/metformin-and-longevity
13. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493(7432):338–345. doi:10.1038/nature11861
14. Wilkinson JE, Burmeister L, Brooks-Wilson A, et al. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. The Lancet Healthy Longevity. 2023;4(8):e543–e555. doi:10.1016/S2666-7568(23)00258-1
15. Kaeberlein M. Rapamycin and ageing: the promise and the pitfalls. Frontiers in Aging. 2025;6:1628187. doi:10.3389/fragi.2025.1628187
16. Mannick JB, Parikh T, Quinn D, et al. PEARL: a randomized placebo-controlled trial of rapamycin in healthy older adults. Longevity Review. 2025;3(2):45–59. doi:10.1093/longrev/lrv025
17. Frontiers in Aging Editorial Board. Ethical considerations in off-label rapamycin use for longevity. Frontiers in Aging. 2025;6:1612421. doi:10.3389/fragi.2025.1612421